SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001269961-03-000001
Filing Date
2003-11-12
Accepted
2003-11-12 19:28:24
Documents
1
Period of Report
2003-11-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1393
  Complete submission text file 0001269961-03-000001.txt   3070
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O NPS PHARMACEUTICALS 420 CHIPETA WAY SALT LAKE CITY UT 84108 8015834939
RAUCH ALAN MARK (Reporting) CIK: 0001269961 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23272 | Film No.: 03995491